You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Filanesib

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Multiple Myeloma Trial in United States (Carfilzomib, proteasome inhibitor; intravenous, Filanesib, KSP(Eg5) inhibitor;

Completed
  • Advanced Multiple Myeloma
  • Carfilzomib, proteasome inhibitor; intravenous
  • +3 more
  • Hot Springs, Arkansas
  • +21 more
Sep 14, 2020

Advanced Multiple Myeloma Trial in Worldwide (Filanesib, KSP (Eg5) inhibitor; intravenous, Filgrastim, granulocyte-colony

Completed
  • Advanced Multiple Myeloma
  • Filanesib, KSP (Eg5) inhibitor; intravenous
  • Filgrastim, granulocyte-colony stimulating factor (G-CSF); subcutaneous
  • Birmingham, Alabama
  • +59 more
Oct 13, 2020

Plasma Cell Leukemia, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Houston (Carfilzomib, Filanesib,

Completed
  • Plasma Cell Leukemia
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 12, 2019

Advanced MDS, Acute Myeloid Leukemia Trial in Atlanta, Houston (ARRY-520, KSP(Eg5) inhibitor; intravenous)

Completed
  • Advanced MDS
  • Acute Myeloid Leukemia
  • ARRY-520, KSP(Eg5) inhibitor; intravenous
  • Atlanta, Georgia
  • +1 more
Feb 4, 2021

Advanced Solid Tumors Trial in Baltimore, Detroit (ARRY-520, KSP(Eg5) inhibitor; intravenous, Filgrastim, granulocyte-colony

Completed
  • Advanced Solid Tumors
  • ARRY-520, KSP(Eg5) inhibitor; intravenous
  • Filgrastim, granulocyte-colony stimulating factor (G-CSF); subcutaneous
  • Baltimore, Maryland
  • +1 more
Sep 24, 2020

Multiple Myeloma Trial in Spain (Pembrolizumab)

Completed
  • Multiple Myeloma
  • Badalona, Spain
  • +10 more
Apr 28, 2020